Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients With Solid Tumors [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating epoetin alfa for treating anemia in patients with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anemia, Leukemia | Phase 3 | Status: COMPLETED